Newsroom | Qiming Venture Partners

06/2022

Portfolio News
OriCell Reports OriCAR-017 Phase I POLARIS study Data in Oral Presentation at American Society of Clinical Oncology (ASCO) Annual Meeting 2022

05/2022

Portfolio News
WeRide received strategic investment from Bosch to jointly develop the auto grade and mass production of advanced driving solution in China
Portfolio News
Insilico Medicine Announced Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
Portfolio News
CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
Portfolio News
Clinical trial results of Belief BioMed's hemophilia B gene therapy drug candidate BBM-H901 published in The Lancet Haematology
Portfolio News
LaNova Medicines and Turning Point Therapeutics Enter into Licensing Agreement for LM-302 Antibody Drug Conjugate Program
Portfolio News
WeRide Reached Strategic Cooperation with Hesai, Leading the Application of Hybrid Solid-State Lidar on L4 Autonomous Vehicle

04/2022

Portfolio News
WeRide announces self-driving Robosweepers roll off the assembly line
Portfolio News
VenusP-Valve™ obtains CE marking under MDR and debuts in Europe as China's first valve product
Qiming News
Qiming’s Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List

03/2022

Portfolio News
Qiming’s Portfolio Company Rendu Biotechnology Lists on STAR Market
Portfolio News
Qiming’s Portfolio Company Arrail Group Lists on Main Board of HKEX
Qiming News
Qiming Monthly Newsletter (February 2022)
Qiming News
Retailers, Logistics Companies to Introduce Affordable Rapid Test Kits in Hong Kong
Qiming News
Qiming Venture Partners Welcomes David Chu as IR Partner

02/2022

Portfolio News
Convidecia Approved as Heterologous Booster in China
Portfolio News
Pluslife Biotech – A Greater Bay Area Company Launches First Handheld Covid-19 Nucleic Acid Test
Qiming News
Qiming Monthly Newsletter (November 2021 - January 2022)

01/2022

Qiming News
Qiming Venture Partners Announces Annual Promotions
Portfolio News
Qiming’s Portfolio Company Asieris Pharmaceuticals Lands on STAR Market
Qiming News
Shiyu Wang Rejoins Qiming Venture Partners as Partner Co-Leads TMT Team

12/2021

Qiming News
Qiming Venture Partners to Hold 13th CEO Summit This Week

11/2021

Qiming News
Nisa Leung on SCMP: How Hong Kong plays a central role in the biotech investment boom
Qiming News
Qiming Participates in $156m round in CRO Firm Tripod

10/2021

Portfolio News
Beijing’ Covid Booster Campaign Includes Cansino’s Vaccine: Bloomberg
Portfolio News
ShouTi Secures $100 Million Series B Financing, Qiming Participated
Qiming News
Qiming Monthly Newsletter October
Qiming News
How China turned the tables on biopharma's global dealmaking: Endpoints News
Portfolio News
WeRide unveils China's first Level 4 self-driving cargo van
Portfolio News
Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D
Portfolio News
Qiming’s Portfolio Company Microtech Medical Lists on Main Board of HKEx
Portfolio News
Qiming’s Portfolio Company Abbisko Lists on Main Board of HKEx

09/2021

Portfolio News
Qiming’s Portfolio Company Broncus Lists on Main Board of HKEx
Portfolio News
Chinese driverless car firm WeRide launches ‘Robovan’ for autonomous deliveries: CNBC
Portfolio News
Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use: Reuters
Portfolio News
CanSino booster shot increases antibodies 78-fold
Portfolio News
Alamar Biosciences Completes $80M Series B Fundraising to Bring Unprecedented Performance to the Proteomics Market
Qiming News
Qiming's Nisa Leung on Investments in China's Biotech Industry: Bloomberg
Qiming News
Qiming Venture Partners Monthly Newsletter | August

08/2021

Portfolio News
‘AI doctor’developer Zuoshouyisheng raises USD 15.5 million in Series B: KrAsia
Portfolio News
Blockchain Startup InfStones Raises $10M in Series A Funding Round: CoinDesk
Portfolio News
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO® (tepotinib)
Portfolio News
China's mRNA vaccine technology firm Abogen raises over $700 mln: Reuters
Portfolio News
InferVision AI Assists the European Commission Monitoring COVID-19 Variants
Portfolio News
InferVision Completes Series D2 Financing Round
Portfolio News
Qiming’s Portfolio Company Sino Biological Lists on Shenzhen’s ChiNext Market
Portfolio News
New Milestone in Kidney Fibrosis: AI-designed Pipeline of Antifibrotic Therapies – Insilico
Portfolio News
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval
Portfolio News
Antengene, MindRank AI to Jointly Develope Difficult-to-Drug Molecular Targets
Qiming News
Qiming Venture Partners Monthly Newsletter | July
Portfolio News
Berry Oncology Completes Series B1 Funding
Portfolio News
Asia's Leading Crypto Financial Services Platform Matrixport Valued at Over $1 Billion
Portfolio News
Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma

07/2021

Portfolio News
Palisade Bio and Newsoara Announce Positive Topline Efficacy Results from Phase 2 Study of LB1148 Demonstrating Accelerated Return of Bowel Function After Gastrointestinal Surgery
Portfolio News
Sinocelltech’s SCT-800 wins NMPA approval; first homegrown drug for hemophilia A
Portfolio News
AI medtech startup InferVision raises USD 139 million in Series D for predictive medicine
Portfolio News
Chinese driverless car start-up WeRide makes first acquisition: CNBC
Portfolio News
Hesai, WeRide form partnership to develop advanced hardware platform for autonomous cars
Portfolio News
Neiwai Raised $100 Million in Series D Funding
Portfolio News
CANbridge CAN106 IND Application Approved in China for the Treatment of PNH

Pages